Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Shanchol is the fastest growing sector, Asia-Pacific is the largest market

The global cholera vaccines market is projected to expand significantly, growing from USD 97.32 Million in 2025 to USD 166.11 Million by 2031 at a 9.32% CAGR. These biological preparations, primarily oral formulations, induce immunity against the Vibrio cholerae bacterium. The market is propelled by the intensifying frequency of cholera outbreaks, largely attributed to climate change phenomena such as severe flooding and droughts that compromise water and sanitation infrastructure. The escalation of humanitarian crises and population displacement further necessitates rigorous mass vaccination campaigns to mitigate morbidity in high-risk zones, with over 40 million oral cholera vaccine doses allocated globally in 2025 to address surging outbreaks and humanitarian emergencies, according to the International Coordinating Group on Vaccine Provision.

Market Drivers

The resurgence of cholera outbreaks in endemic regions, heavily influenced by climate change-induced events like severe floods and cyclones contaminating water, serves as the primary catalyst driving the market's urgent expansion. This escalation, which led to 409,222 cholera cases and over 4,700 deaths between January and August 2025 as reported by the WHO, has rapidly depleted existing stockpiles, creating an immediate need for replenishment and distribution. Additionally, advancements in vaccine formulation and the expansion of manufacturing infrastructure are reshaping supply dynamics; pharmaceutical companies and global alliances are investing in high-capacity production facilities and streamlining regulatory approvals, exemplified by Bharat Biotech's plan for 200 million doses annually and EuBiologics Co., Ltd's commitment to supply 72 million doses to UNICEF in 2025.

Market Challenges

Despite this robust demand and production efforts, the market faces a significant barrier: insufficient global production capacity relative to immediate public health requirements. This manufacturing bottleneck creates a hard ceiling on market volume, preventing the industry from capitalizing on demand, resulting in severe stockpile shortages, forced dose rationing strategies, delayed response times in endemic regions, and restricted geographical expansion. This persistent gap, where requests for 13.9 million doses in Q1 2025 alone rapidly depleted stock, remains the primary restraint hindering broader market expansion and timely disease elimination efforts.

Market Trends

In parallel, two key trends are influencing the market: the growth in the private travel market and prophylactic vaccination demand, offering a lucrative segment with higher price points from international tourists to endemic zones, as shown by Valneva SE's Dukoral vaccine sales growing to €17.4 million in H1 2025. Simultaneously, there's a diversification of the global manufacturing and supply base, shifting production geography to reduce reliance on Asian incumbents and enhance regional health security. This involves funding technology transfers to local manufacturers, particularly in Africa, to decentralize the supply chain and ensure indigenous end-to-end capabilities, such as Biovac in South Africa commencing Phase 1 clinical trials for its locally manufactured oral cholera vaccine in October 2025.

Key Market Players

• Valneva SE
• Sanofi S.A.
• Emergent BioSolutions Inc.
• EuBiologics Co., Ltd.
• Shantha Biotechnics Limited
• Hilleman Laboratories Singapore Pte Ltd
• Astellas Pharma Inc.
• Incepta Pharmaceuticals Ltd.
• Bharat Biotech Ltd.
• Takeda Pharmaceutical Company Limited

Report Scope

In this report, the Global Cholera Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cholera Vaccines Market, by Type:

• Whole cell V. Cholerae O1 Recombinant With B-Subunit
• Killed Oral O1 & O139

Cholera Vaccines Market, by Product:

• Vaxchora
• Dukoral
• Shanchol
• Others

Cholera Vaccines Market, by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Others

Cholera Vaccines Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cholera Vaccines Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.